ATE323781T1 - Diagnostischer test für die alzheimersche krankheit - Google Patents

Diagnostischer test für die alzheimersche krankheit

Info

Publication number
ATE323781T1
ATE323781T1 AT98946146T AT98946146T ATE323781T1 AT E323781 T1 ATE323781 T1 AT E323781T1 AT 98946146 T AT98946146 T AT 98946146T AT 98946146 T AT98946146 T AT 98946146T AT E323781 T1 ATE323781 T1 AT E323781T1
Authority
AT
Austria
Prior art keywords
ache
glycosylation pattern
sample
alzheimer
disease
Prior art date
Application number
AT98946146T
Other languages
German (de)
English (en)
Inventor
David Henry Small
Javier Saez-Valero
Gian Sberna
Original Assignee
Univ Monash
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Monash filed Critical Univ Monash
Application granted granted Critical
Publication of ATE323781T1 publication Critical patent/ATE323781T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/827—Actinoplanes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT98946146T 1997-09-24 1998-09-24 Diagnostischer test für die alzheimersche krankheit ATE323781T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO9432A AUPO943297A0 (en) 1997-09-24 1997-09-24 Diagnostic test for alzheimer's disease

Publications (1)

Publication Number Publication Date
ATE323781T1 true ATE323781T1 (de) 2006-05-15

Family

ID=3803714

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98946146T ATE323781T1 (de) 1997-09-24 1998-09-24 Diagnostischer test für die alzheimersche krankheit

Country Status (11)

Country Link
US (1) US6461831B1 (cg-RX-API-DMAC7.html)
EP (1) EP1017845B1 (cg-RX-API-DMAC7.html)
JP (1) JP2001517456A (cg-RX-API-DMAC7.html)
AT (1) ATE323781T1 (cg-RX-API-DMAC7.html)
AU (1) AUPO943297A0 (cg-RX-API-DMAC7.html)
BR (1) BR9813015A (cg-RX-API-DMAC7.html)
CA (1) CA2304949A1 (cg-RX-API-DMAC7.html)
DE (1) DE69834263D1 (cg-RX-API-DMAC7.html)
HU (1) HUP0003684A3 (cg-RX-API-DMAC7.html)
IL (1) IL135211A0 (cg-RX-API-DMAC7.html)
WO (1) WO1999015695A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL130225A0 (en) * 1999-05-31 2000-06-01 Yissum Res Dev Co Novel uses of antibodies against ache and peptides thereof
US20020150878A1 (en) * 2001-01-23 2002-10-17 Small David Henry Method for the diagnosis of Alzheimer's Disease and other prion related disorders
WO2004066808A2 (en) * 2002-12-20 2004-08-12 Momenta Pharmaceuticals, Inc. Glycan markers for diagnosing and monitoring disease
GB2404734A (en) * 2003-08-05 2005-02-09 Secr Defence A method of screening a sample for abnormally glycosylated and/or expressed proteins
US7598049B2 (en) * 2003-11-19 2009-10-06 Satoris, Inc. Methods for diagnosis of Alzheimer's Disease in blood samples
US20060094064A1 (en) * 2003-11-19 2006-05-04 Sandip Ray Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids
US20050272643A1 (en) * 2004-06-08 2005-12-08 Windber Research Institute Removal of serum albumin from human serum or plasma
US7851172B2 (en) * 2006-07-25 2010-12-14 University Of Kentucky Research Foundation Biomarkers of mild cognitive impairment and alzheimer's disease
US20100124756A1 (en) * 2008-10-10 2010-05-20 Sandip Ray Collection of biomarkers for diagnosis and monitoring of alzheimer's disease in body fluids
US20110237537A1 (en) * 2009-05-29 2011-09-29 Lombard Jay L Methods for assessment and treatment of mood disorders via single nucleotide polymorphisms analysis
US8355927B2 (en) 2010-11-05 2013-01-15 Genomind, Llc Neuropsychiatric test reports
US9493834B2 (en) 2009-07-29 2016-11-15 Pharnext Method for detecting a panel of biomarkers
US20110202284A1 (en) * 2010-02-10 2011-08-18 Mcreynolds Cristopher Novel groups of biomarkers for diagnosing alzheimer's disease
ES2395063B1 (es) * 2011-03-04 2014-02-07 Universidad Miguel Hernández De Elche Método para determinar la enfermedad de Alzheimer mediante la detección de glicoproteínas portadoras del glicoepítopo HNK-1
EP3255435A1 (en) 2012-04-13 2017-12-13 Oasis Diagnostics Corporation Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595883A (en) * 1990-06-01 1997-01-21 E. R. Squibb & Sons, Inc. Method of diagnosing alzheimer's disease by measuring acetylcholinesterase activity in ocular fluid
CA2048700A1 (en) 1990-09-04 1992-03-05 Dasakumar S. Navaratnam Method for diagnosing senile dementia of the alzheimer type
US5200324A (en) * 1990-09-04 1993-04-06 E. R. Squibb & Sons, Inc. Method of diagnosing senile dementia of the Alzheimer type

Also Published As

Publication number Publication date
HUP0003684A3 (en) 2003-04-28
BR9813015A (pt) 2000-08-15
CA2304949A1 (en) 1999-04-01
JP2001517456A (ja) 2001-10-09
DE69834263D1 (de) 2006-05-24
EP1017845A1 (en) 2000-07-12
AUPO943297A0 (en) 1997-10-16
US6461831B1 (en) 2002-10-08
HUP0003684A2 (hu) 2001-02-28
IL135211A0 (en) 2001-05-20
EP1017845B1 (en) 2006-04-19
EP1017845A4 (en) 2003-07-02
WO1999015695A1 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
DE69834263D1 (de) Diagnostischer test für die alzheimersche krankheit
GB2380546A (en) Process for differential diagnosis of alzheimer's dementia and device therefor
AT500379B1 (de) Tau-proteine
ATE223051T1 (de) Verfahren zur diagnose gutartiger prostataerkrankungen
GB9524934D0 (en) Treatment and diagnosis of infections due to helicobacter pylori
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
ATE234466T1 (de) Verfahren zur feststellung von antipolymerantikörper und diagnosetestsatz zur feststellung von siliconabhängigen krankheiten
DE69333076D1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
JP2001517456A5 (cg-RX-API-DMAC7.html)
WO2002041842A3 (en) Antibody pti-hs7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease
WO1995005604A3 (en) Methods for the diagnosis of alzheimer's disease
DE60224200D1 (de) Assayverfahren für alzheimer-krankheit
ATE343597T1 (de) Diagnostisches assay für typ-2-heparin induzierte thrombocytopenie
BR0109915A (pt) Teste de diagnóstico para doença de alzheimer
AU2579995A (en) Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
ATA19972000A (de) Pibf für die diagnose von tumoren
WO2002082077A3 (de) Herstellung polyklonaler, monospezifischer antikörper gegen die upar-varianten del4, del5 und del4+5 sowie deren verwendung für diagnostische und therapeutische zwecke
ATE209359T1 (de) Bestimmung von freiem und komplexiertem trypsinogen-2
US20020177171A1 (en) Method and means for caries prevention and susceptibility detection
PT1297342E (pt) Metodo de diagnostico para a doenca de alzheimer com base em holo-transcobalamina ii
UA10262A (uk) Спосіб ультразвукової діагностики стану судин головного мозку
Katelaris et al. Response to Dr. Laheijet al.
MY133261A (en) Allergenic proteins of natural rubber latex, their production and use in assays
UA29311A (uk) Спосіб диференційної діагностики аменореї у дівчатпідлітків
UA37731A (uk) Спосіб діагностики розсіяного склерозу

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties